Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II—clinical practice guideline appraisal for lipid management in coronary heart disease-Reference-Cited by-同舟云学术

Lipid management for coronary heart disease patients: an appraisal of updated international guidelines applying Appraisal of Guidelines for Research and Evaluation II—clinical practice guideline appraisal for lipid management in coronary heart disease

Published:2019-08 Issue:8 Volume:11 Page:3534-3546
ISSN:2072-1439
Container-title:Journal of Thoracic Disease
language:
Short-container-title:J. Thorac. Dis.

Author:

Zhou Huimin,Zhang Shaozhao,Sun Xiuting,Yang Daya,Zhuang Xiaodong,Guo Yue,Hu Xun,Du Zhimin,Zhang Meifen,Liao Xinxue

Publisher

AME Publishing Company

Subject

Pulmonary and Respiratory Medicine

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methodological Quality of Pulmonary Arterial Hypertension Treatment Evidence-Based Guidelines: A Systematic Review Using the AGREE II and AGREE REX Tools;Cardiovascular Drugs and Therapy;2024-07-09

2. Methodological quality and clinical recommendations of guidelines on the management of dyslipidaemias for cardiovascular disease risk reduction: a systematic review and an appraisal through AGREE II and AGREE REX tools;Family Practice;2024-06-04

3. Clinical value of long non‐coding RNA KCNQ1OT1 in estimating the stenosis, lipid level, inflammation status, and prognostication in coronary heart disease patients;Journal of Clinical Laboratory Analysis;2022-12

4. Ethnicity affects the risk factors of acute myocardial infarction and should be considered in educational programs;Frontiers in Cardiovascular Medicine;2022-10-19

5. lncRNA MALAT1/miR-143 axis is a potential biomarker for in-stent restenosis and is involved in the multiplication of vascular smooth muscle cells;Open Life Sciences;2021-01-01